Raymond James & Associates’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,154
| Closed | -$279K | – | 3827 |
|
|
2020
Q4 | $279K | Buy |
6,154
+492
| +9% | +$22.3K | ﹤0.01% | 3135 |
|
|
2020
Q3 | $200K | Sell |
5,662
-65
| -1% | -$2.3K | ﹤0.01% | 3187 |
|
|
2020
Q2 | $216K | Buy |
+5,727
| New | +$216K | ﹤0.01% | 3059 |
|
|
2020
Q1 | – | Sell |
-5,905
| Closed | -$306K | – | 3401 |
|
|
2019
Q4 | $306K | Sell |
5,905
-58
| -1% | -$3.01K | ﹤0.01% | 3055 |
|
|
2019
Q3 | $327K | Sell |
5,963
-1,380
| -19% | -$75.7K | ﹤0.01% | 2938 |
|
|
2019
Q2 | $298K | Sell |
7,343
-378
| -5% | -$15.3K | ﹤0.01% | 2999 |
|
|
2019
Q1 | $233K | Buy |
7,721
+1,600
| +26% | +$48.3K | ﹤0.01% | 3116 |
|
|
2018
Q4 | $206K | Sell |
6,121
-1,259
| -17% | -$42.4K | ﹤0.01% | 3095 |
|
|
2018
Q3 | $311K | Sell |
7,380
-278
| -4% | -$11.7K | ﹤0.01% | 2987 |
|
|
2018
Q2 | $245K | Buy |
7,658
+3,498
| +84% | +$112K | ﹤0.01% | 3122 |
|
|
2018
Q1 | $207K | Buy |
+4,160
| New | +$207K | ﹤0.01% | 3099 |
|
|
2013
Q4 | – | Sell |
-13,787
| Closed | -$329K | – | 1953 |
|
|
2013
Q3 | $329K | Buy |
13,787
+601
| +5% | +$14.3K | ﹤0.01% | 1747 |
|
|
2013
Q2 | $224K | Buy |
+13,186
| New | +$224K | ﹤0.01% | 1805 |
|